Cargando…
Nanog maintains stemness of Lkb1‐deficient lung adenocarcinoma and prevents gastric differentiation
Growing evidence supports that LKB1‐deficient KRAS‐driven lung tumors represent a unique therapeutic challenge, displaying strong cancer plasticity that promotes lineage conversion and drug resistance. Here we find that murine lung tumors from the Kras(LSL‐G12D/+); Lkb1(flox/flox) (KL) model show st...
Autores principales: | Tong, Xinyuan, Chen, Yueqing, Zhu, Xinsheng, Ye, Yi, Xue, Yun, Wang, Rui, Gao, Yijun, Zhang, Wenjing, Gao, Weiqiang, Xiao, Lei, Chen, Haiquan, Zhang, Peng, Ji, Hongbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933951/ https://www.ncbi.nlm.nih.gov/pubmed/33439550 http://dx.doi.org/10.15252/emmm.202012627 |
Ejemplares similares
-
Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma
por: Han, Xiangkun, et al.
Publicado: (2014) -
Author Correction: Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma
por: Han, Xiangkun, et al.
Publicado: (2022) -
Lkb1 maintains T(reg) cell lineage identity
por: Wu, Di, et al.
Publicado: (2017) -
PHC1 maintains pluripotency by organizing genome-wide chromatin interactions of the Nanog locus
por: Chen, Li, et al.
Publicado: (2021) -
LKB1 deficiency upregulates RELM-α to drive airway goblet cell metaplasia
por: Li, Yu, et al.
Publicado: (2021)